Kyowa Kirin Co., Ltd. (TYO:4151)
Japan · Delayed Price · Currency is JPY 2,402.50
+32.50 (1.37%)
At close: Feb 6, 2026
Kyowa Kirin Market Cap
Kyowa Kirin has a market cap or net worth of 1.26 trillion as of February 6, 2026. Its market cap has increased by 6.05% in one year.
Market Cap
1.26T
Enterprise Value
1.04T
Revenue
482.21B
Ranking
n/a
PE Ratio
34.40
Stock Price
2,402.50
Market Cap Chart
Since May 6, 1994, Kyowa Kirin's market cap has increased from 435.63B to 1.26T, an increase of 188.70%. That is a compound annual growth rate of 3.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 1.26T | -4.93% |
| Dec 30, 2025 | 1.32T | 9.41% |
| Dec 30, 2024 | 1.21T | -5.11% |
| Dec 29, 2023 | 1.27T | -21.50% |
| Dec 30, 2022 | 1.62T | -3.64% |
| Dec 30, 2021 | 1.68T | 11.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 14.32T |
| Daiichi Sankyo Company | 5.37T |
| Otsuka Holdings | 4.97T |
| Astellas Pharma | 4.03T |
| Ono Pharmaceutical | 1.14T |
| Santen Pharmaceutical | 530.74B |
| JCR Pharmaceuticals | 74.90B |
| Perseus Proteomics | 3.55B |